1800 246 235 / 3550043

info@biocells.med.ec

Presencia en

las 24 provincias del Ecuador

Síguenos

Protocolos de acceso expandido

de Parálisis Cerebral y Autismo

1/160 niños
en el mundo tienen autismo

1/300 nacidos vivos
tienen Parálisis Cerebral

1/45 nacidos prematuros
tienen Parálisis Cerebral

La Universidad de Duke en Octubre de 2017 lanzó el Primer programa de acceso ampliado con Células Madre de Sangre de Cordón Umbilical para Parálisis Cerebral y Autismo que permite a los niños con estos trastornos recibir el tratamiento con su propia unidad de Sangre de Cordón Umbilical.

Al ser un protocolo de acceso ampliado permite que un paciente con una enfermedad grave, que no ha encontrado una terapia eficaz para su condición, tenga la posibilidad de usar un producto médico que se ha demostrado que es seguro pero que no ha sido comercializado por el momento.

A través del convenio con FAMICORD nuestros clientes pueden acceder al programa de tratamiento de acceso ampliando basado en protocolo de la Universidad de Duke.

Ensayos Clínicos

El potencial de las Células Madre de Sangre de Cordón Umbilical en la medicina regenerativa están en constante estudio. Te mostramos las últimas novedades científicas.

 

 

Código NCT Categoría Fases Estatus Localización URL
NCT03735277 Accidente Cerebro Vascular Fase 1 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03735277
NCT03004976 Accidente Cerebro Vascular Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03004976
NCT03913312 Leucemia mieloide Aguda Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT03913312
NCT03431480 Síndrome del corazón izquierdo hipoplásico Fase 1 Reclutando Australia https://ClinicalTrials.gov/show/NCT03431480
NCT01856049 Síndrome del corazón izquierdo hipoplásico N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01856049
NCT03441958 Mieloma Múltiple Fase 1|Fase 2 Reclutando Canadá https://ClinicalTrials.gov/show/NCT03441958
NCT01451502 Trastorno linfático N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01451502
NCT04172181 SCID N/A Activo, no recluta China https://ClinicalTrials.gov/show/NCT04172181
NCT04170192 Enfermedad Inflamatoria Intestinal N/A Activo, no recluta China https://ClinicalTrials.gov/show/NCT04170192
NCT04420494 Citopenia N/A Reclutando China https://ClinicalTrials.gov/show/NCT04420494
NCT03526588 Enfermedad congénita Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03526588
NCT01861093 Anemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01861093
NCT01861093 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01861093
NCT01861093 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01861093
NCT01861093 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01861093
NCT04243382 Autismo Fase 2 No recluta aún Israel https://ClinicalTrials.gov/show/NCT04243382
NCT04007224 Autismo Fase 1 Solo con invitación Rumania https://ClinicalTrials.gov/show/NCT04007224
NCT02551003 Encefalopatía hipóxico-isquémica Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT02551003
NCT02745717 Anemia Fase 4 Reclutando China https://ClinicalTrials.gov/show/NCT02745717
NCT02455830 Encefalopatía hipóxico-isquémica N/A Activo, no recluta Japon https://ClinicalTrials.gov/show/NCT02455830
NCT01553461 Mielodisplasia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01553461
NCT01553461 Anemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01553461
NCT04440670 Trastorno Mental Fase 3 No recluta aún China https://ClinicalTrials.gov/show/NCT04440670
NCT03881774 Linfoma Fase 1 Reclutando China https://ClinicalTrials.gov/show/NCT03881774
NCT04243408 Parálisis cerebral Fase 2 No recluta aún Israel https://ClinicalTrials.gov/show/NCT04243408
NCT03696745 Daño cerebral Fase 1 No recluta aún China https://ClinicalTrials.gov/show/NCT03696745
NCT01768845 Leucemia N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01768845
NCT01768845 Linfoma N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01768845
NCT01768845 Anemia N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01768845
NCT01351545 Leucemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01351545
NCT01351545 Linfoma N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01351545
NCT01351545 Anemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01351545
NCT01351545 Desorden del Sistema Inmune N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01351545
NCT01351545 Desorden Metabólico N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01351545
NCT02103296 Anemia N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02103296
NCT01247701 Trastornos Hematológicos N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01247701
NCT00604201 Mielodisplasia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00604201
NCT00604201 Anemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00604201
NCT00739141 Leucemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00739141
NCT00739141 Linfoma Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00739141
NCT00739141 Mielodisplasia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00739141
NCT00950846 Defecto congénito N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00950846
NCT03913026 Trastornos Hematológicos Fase 2 Reclutando Canada https://ClinicalTrials.gov/show/NCT03913026
NCT02932826 Diabetes Tipo 1 Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT02932826
NCT01883076 Síndrome del corazón izquierdo hipoplásico Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01883076
NCT03473301 Parálisis cerebral Fase 1|Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03473301
NCT02433509 Accidente Cerebro Vascular Fase 1 Reclutando China https://ClinicalTrials.gov/show/NCT02433509
NCT03779711 Síndrome del corazón izquierdo hipoplásico Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03779711
NCT02730299 Leucemia Fase 3 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02730299
NCT02730299 Linfoma Fase 3 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02730299
NCT02730299 Mielodisplasia Fase 3 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02730299
NCT01962636 Leucemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962636
NCT01962636 Linfoma N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962636
NCT01962636 Mieloma N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962636
NCT01962636 Mielodisplasia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962636
NCT03096782 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03096782
NCT03096782 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03096782
NCT03096782 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03096782
NCT03483324 Leucemia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03483324
NCT03483324 Mielodisplasia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03483324
NCT01690520 Leucemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01690520
NCT01690520 Linfoma Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01690520
NCT01619761 Leucemia Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01619761
NCT01619761 Linfoma Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01619761
NCT01619761 Mieloma Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01619761
NCT01619761 Mielodisplasia Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01619761
NCT04013646 Accidente Cerebro Vascular Fase 1|Fase 2 Reclutando Corea https://ClinicalTrials.gov/show/NCT04013646
NCT04083170 Leucemia Fase 2 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT04083170
NCT04083170 VIH Fase 2 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT04083170
NCT04083170 Mielodisplasia Fase 2 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT04083170
NCT03979742 Lesión Medula Espinal Fase 2 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03979742
NCT03885947 Leucemia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03885947
NCT03885947 Linfoma Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03885947
NCT03885947 Mielodisplasia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03885947
NCT02727803 Leucemia N/A Reclutando China https://clinicaltrials.gov/ct2/show/NCT02727803
NCT03016806 Trastorno hematológico Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03016806
NCT03016806 Trastorno metabólico Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03016806
NCT03016806 Anemia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03016806
NCT02140944 HIV N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02140944
NCT03835312 Diabetes Tipo 1 N/A Reclutando China https://ClinicalTrials.gov/show/NCT03835312
NCT04103879 Trastornos hematológicos Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT04103879
NCT04393415 COVID-19 N/A No recluta aún Egipto https://ClinicalTrials.gov/show/NCT04393415
NCT03011021 Diabetes Tipo 1 Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT03011021
NCT03173937 Anemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03173937
NCT03173937 Mielodisplasia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03173937
NCT00719888 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00719888
NCT00719888 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00719888
NCT00719888 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00719888
NCT00719888 Anemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00719888
NCT03739502 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03739502
NCT03739502 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03739502
NCT03739502 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03739502
NCT03826498 Parálisis cerebral Fase 2 Activo, no recluta Rusia https://ClinicalTrials.gov/show/NCT03826498
NCT03093844 Trastorno hematológico N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03093844
NCT00796068 Leucemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00796068
NCT00796068 Mielodisplasia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00796068
NCT03019640 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03019640
NCT03558269 trastorno neonatal Fase 1|Fase 2 Reclutando Israel https://ClinicalTrials.gov/show/NCT03558269
NCT03558269 trastorno cardiaco congénito Fase 1|Fase 2 Reclutando Israel https://ClinicalTrials.gov/show/NCT03558269
NCT01729091 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01729091
NCT01729091 Mieloma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01729091
NCT02280525 Leucemia Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02280525
NCT00547196 Leucemia N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00547196
NCT00547196 Linfoma N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00547196
NCT00547196 Mielodisplasia N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00547196
NCT04099381 Autismo Fase 1|Fase 2 Reclutando Rusia https://ClinicalTrials.gov/show/NCT04099381
NCT03056339 Leucemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03056339
NCT03056339 Linfoma Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03056339
NCT03802773 Trastorno hematológico Reclutando Italia https://ClinicalTrials.gov/show/NCT03802773
NCT03594981 Inmunoterapia antiviral Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03594981
NCT03876821 Anemia N/A No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03876821
NCT03941769 Leucemia Fase 1 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03941769
NCT03941769 Mielodisplasia Fase 1 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03941769
NCT03434730 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03434730
NCT03434730 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03434730
NCT03434730 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03434730
NCT02508324 Leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02508324
NCT02508324 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02508324
NCT04003857 Displasia broncopulmonar Fase 2 Reclutando Corea https://ClinicalTrials.gov/show/NCT04003857
NCT03420963 Tumores solidos Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03420963
NCT02722668 leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02722668
NCT02722668 Linfoma Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02722668
NCT01927731 Fallo Medular Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01927731
NCT01632475 Displasia broncopulmonar N/A Activo, no recluta Corea https://ClinicalTrials.gov/show/NCT01632475
NCT02254863 Trastorno metabólico Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02254863
NCT01586455 Trastorno metabólico Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01586455
NCT00919503 Trastorno hematológico Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00919503
NCT03773393 Fallo Medular Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03773393
NCT03773328 Síndrome Guillain-Barré Fase 1 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03773328
NCT03392467 Displasia broncopulmonar Fase 2 Reclutando Corea https://ClinicalTrials.gov/show/NCT03392467
NCT03719534 Trastornos hematológicos N/A Reclutando China https://ClinicalTrials.gov/show/NCT03719534
NCT00357565 leucemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00357565
NCT00357565 Mielodisplasia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00357565
NCT00357565 Anemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00357565
NCT02046291 Trastornos hematológicos Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02046291
NCT01590628 Anemia Fase 1|Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01590628
NCT01590628 Talasemia Fase 1|Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01590628
NCT01962415 Fallo Medular Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962415
NCT01962415 Anemia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962415
NCT01962415 Trastorno metabólico Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01962415
NCT00408447 Anemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00408447
NCT00408447 Talasemia Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00408447
NCT03406962 Trastorno metabólico Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03406962
NCT03158896 Injerto contra huésped (GVHD) Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03158896
NCT04098029 Parálisis cerebral Fase 2 Reclutando Rusia https://ClinicalTrials.gov/show/NCT04098029
NCT03634501 Tumores solidos Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT03634501
NCT01810588 Trastornos hematológicos Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01810588
NCT04260698 Trastornos hematológicos Fase 3 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT04260698
NCT04324996 COVID-19 Fase 1|Fase 2 Reclutando China https://ClinicalTrials.gov/show/NCT04324996
NCT04418557 COVID-19 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT04418557
NCT02251821 Mielofibrosis Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02251821
NCT03635450 Encefalopatía hipóxico-isquémica Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT03635450
NCT04379284 COVID-19 No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT04379284
NCT00012545 Anemia Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT00012545
NCT04360811 COVID-19 N/A Reclutando Francia https://ClinicalTrials.gov/show/NCT04360811
NCT01020539 Leucemia Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01020539
NCT01020539 Mielodisplasia Fase 1 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01020539
NCT03378063 Displasia broncopulmonar Fase temprana 1 Reclutando China https://ClinicalTrials.gov/show/NCT03378063
NCT04347616 Leucemia Fase 1|Fase 2 No recluta aún Holanda https://ClinicalTrials.gov/show/NCT04347616
NCT01174875 Trastorno Mental N/A Activo, no recluta Singapur https://ClinicalTrials.gov/show/NCT01174875
NCT01174875 Trastorno Metabólico N/A Activo, no recluta Singapur https://ClinicalTrials.gov/show/NCT01174875
NCT02065596 Anemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02065596
NCT01050855 Inmunodeficiencia Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01050855
NCT04140747 Colonización Microbiana N/A Reclutando Austria https://ClinicalTrials.gov/show/NCT04140747
NCT02184676 Diabetes Tipo 1 N/A Activo, no recluta Francia https://ClinicalTrials.gov/show/NCT02184676
NCT04213131 Lesión Medula Espinal N/A Reclutando China https://ClinicalTrials.gov/show/NCT04213131
NCT02179359 Anemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02179359
NCT02179359 Síndrome Shwachman-Diamond N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02179359
NCT02179359 Talasemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02179359
NCT02179359 Trombastenia de Glanzmann N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02179359
NCT02179359 Fallo Medular N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02179359
NCT03904134 Leucemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03904134
NCT03904134 Linfoma N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03904134
NCT03904134 Anemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03904134
NCT00574496 Linfoma Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00574496
NCT03513328 Trastorno Hereditario Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03513328
NCT03513328 Anemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03513328
NCT03513328 Fallo Medular Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03513328
NCT03513328 Talasemia Fase 1|Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03513328
NCT01033552 Epidermólisis Bullosa Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01033552
NCT01366092 Enfermedad injerto contra Huésped (GVHD) Fase 2 Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT01366092
NCT03393611 Leucemia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03393611
NCT03393611 Mielodisplasia Fase 1 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03393611
NCT01685411 Leucemia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01685411
NCT01685411 Mielodisplasia N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01685411
NCT04008849 Desorden Metabólico N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT04008849
NCT04353544 Hemorragia post parto N/A Reclutando Italia https://ClinicalTrials.gov/show/NCT04353544
NCT01652092 Trastorno Hereditario N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT01652092
NCT04369313 Diabetes Tipo 1 N/A Reclutando China https://ClinicalTrials.gov/show/NCT04369313
NCT04369313 Asfixia neonatal N/A Reclutando China https://ClinicalTrials.gov/show/NCT04369313
NCT02878850 Lesión Medula Espinal N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02878850
NCT04395924 COVID-19 Reclutando Francia https://ClinicalTrials.gov/show/NCT04395924
NCT00913471 Lesión Medula Espinal N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT00913471
NCT02396823 Lesión Medula Espinal N/A Activo, no recluta Estados Unidos https://ClinicalTrials.gov/show/NCT02396823
NCT03949660 Disfunción intestinal neurógena N/A No recluta aún Estados Unidos https://ClinicalTrials.gov/show/NCT03949660
NCT03681314 Encefalopatía hipóxico-isquémica N/A No recluta aún India https://ClinicalTrials.gov/show/NCT03681314
NCT03682042 Encefalopatía hipóxico-isquémica N/A No recluta aún India https://ClinicalTrials.gov/show/NCT03682042
NCT02893553 Lesión Medula Espinal Fase 2 Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT02893553
NCT03621943 Trastorno neuronal N/A Reclutando Canadá https://ClinicalTrials.gov/show/NCT03621943
NCT03690700 Lesión Medula Espinal N/A No recluta aún Dinamarca https://ClinicalTrials.gov/show/NCT03690700
NCT03621956 Asfixia neonatal N/A Reclutando Canadá https://ClinicalTrials.gov/show/NCT03621956
NCT03505463 Lesión Medula Espinal N/A Reclutando Dinamarca https://ClinicalTrials.gov/show/NCT03505463
NCT03657394 Encefalopatía hipóxico-isquémica Fase 3 No recluta aún India https://ClinicalTrials.gov/show/NCT03657394
NCT03998527 Lesión Medula Espinal N/A Reclutando Estados Unidos https://ClinicalTrials.gov/show/NCT03998527
NCT02859792 Lesión Medula Espinal Fase 2 No recluta aún Francia https://ClinicalTrials.gov/show/NCT02859792
NCT04687657 Leucemia Fase 1 No reclutando China https://ClinicalTrials.gov/show/NCT04687657
NCT04768816 Autismo Fase 1 Reclutando China https://clinicaltrials.gov/ct2/show/NCT04768816
NCT04566757 Daño cerebral Fase 1 No Reclutando USA https://ClinicalTrials.gov/show/NCT04566757
NCT04174586 Leucemia mieloide Fase 1 Reclutando China https://ClinicalTrials.gov/show/NCT04174586
NCT04636853 Retinitis Pigmentosa Fase 3 Reclutando Italia https://ClinicalTrials.gov/show/NCT04636853
NCT04689425 Pie Diabético Fase 3 No Reclutando China https://ClinicalTrials.gov/show/NCT04689425
NCT04594031 Anemia Fase 1 No reclutando USA https://ClinicalTrials.gov/show/NCT04594031
NCT04710810 Autismo Fase 1  No reclutando China https://ClinicalTrials.gov/show/NCT03791372
NCT04644016 Leucemia Fase 2 Reclutando USA https://ClinicalTrials.gov/show/NCT04644016
NCT04707300 Leucemia mieloide Fase 1/Fase 2 No reclutando Francia https://ClinicalTrials.gov/show/NCT04707300
NCT04393415 Covid-19 N/A Reclutando Egipto https://ClinicalTrials.gov/show/NCT04393415
NCT04632316 Leucemia mieloide Fase 1/Fase 2 Reclutando Varios https://ClinicalTrials.gov/show/NCT04632316
NCT02039557 Expansión celular N/A No reclutando USA https://ClinicalTrials.gov/show/NCT02039557
NCT03441958 Expansión celular Fase 1/Fase 2 Reclutando Canadá https://ClinicalTrials.gov/show/NCT03441958
NCT03913026 Expansión celular  Fase 2 Reclutando Canadá https://ClinicalTrials.gov/show/NCT03913026
NCT03791372 Parálisis Cerebral Fase 1 Reclutando China https://ClinicalTrials.gov/show/NCT03791372

× ¿Cómo puedo ayudarte?